![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Chief Tech/Sci/R&D Officer at
KYMERA THERAPEUTICS, INC.
Net worth: 6 M $ as of 2026-05-30
Profile
Dr. Jared Gollob, MD, is a Chief Medical Officer at Kymera Therapeutics, Inc. Dr. Gollob was previously employed as a Global VP-Medical Affairs & Clinical Development by Alnylam Pharmaceuticals, Inc. and a Director-Biologic Therapy Program by Duke University.
He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 71,359 ( 0.09% ) | 6 M $ | 2026-05-30 |
Jared Gollob active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-08-31 |
Former positions of Jared Gollob
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-07-31 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2007-08-31 |
Training of Jared Gollob
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Stock Market
- Insiders
- Jared Gollob
